J. L. Marshall

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna C. Bendell et al. · The Lancet Oncology · 2019 · 562 citations · Full text

Medicine, Oncology, Pharmacology +11

TNM staging of pancreatic carcinoma using helical CT.

R K Zeman, Cirrelda Cooper, Andrew S. Zeiberg et al. · American Journal of Roentgenology · 1997 · 113 citations

Medicine, Radiology, Surgery +14

A multicenter, phase II study of CPX-1 liposome injection in patients (pts) with advanced colorectal cancer (CRC)

Gerald Batist, M. B. Sawyer, N. Gabrail et al. · Journal of Clinical Oncology · 2008 · 37 citations

Pharmacy, Oncology, Pharmacology +17

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database

Mohamed E. Salem, Jun Yin, Richard M. Goldberg et al. · Annals of Oncology · 2020 · 34 citations · Full text

Medicine, Oncology, Chemotherapy +12

A phase I study of brivanib alaninate (BMS-582664), an oral dual inhibitor of VEGFR and FGFR tyrosine kinases, in combination with full dose cetuximab (BC) in patients (pts) with advanced gastrointestinal malignancies (AGM) who failed prior therapy

Chris R. Garrett, Lillian L. Siu, Anthony B. El-Khoueiry et al. · Journal of Clinical Oncology · 2008 · 17 citations

Medicine, Oncology, Pharmacology +15